Target intelligence / Profile preview

Potassium Voltage-Gated Channel Subfamily H Member 2 (hERG)

Target
hERG
Molecular classification
Ion channel, Voltage-gated potassium channel
01

Overview

Potassium Voltage-Gated Channel Subfamily H Member 2 (hERG), also known as Kv11.1, is a voltage-dependent potassium channel crucial for cardiac action potential repolarization. Encoded by the KCNH2 gene, hERG is a tetramer forming a pore in the plasma membrane. Its unique structure, including a central cavity with hydrophobic pockets, makes it susceptible to blockade by various drugs, leading to potential cardiac arrhythmias like Long QT syndrome and Torsade de pointes. hERG contains cytoplasmic domains such as the PAS domain in the N-terminus and a cyclic nucleotide binding domain (cNBD) in the C-terminus.

Other names
KCNH2Eag homologEag-related protein 1ERGERG-1ERG1Ether-a-go-go-related gene potassium channel 1Ether-a-go-go-related protein 1H-ERGHERGhERG-1hERG1Voltage-gated potassium channel subunit Kv11.1
02

Mechanism of action

hERG channel blockade

03

Biological functions

Cardiac action potential repolarizationRegulation of QT intervalPotassium ion transmembrane transport
04

Disease associations

Long QT Syndrome (LQTS)Cardiac arrhythmiasTorsade de pointes
05

Safety considerations

Drug-induced Long QT SyndromeDrug-induced Torsade de pointesPotential for drug withdrawal due to hERG inhibition
06

Interacting drugs

Terfenadine

Beyond the preview

Go deeper on Potassium Voltage-Gated Channel Subfamily H Member 2 (hERG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium Voltage-Gated Channel Subfamily H Member 2 (hERG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call